Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Microbiome in Lung Cancer and Other Malignancies

NCT03688347 is registered in ClinicalTrials.gov with Taher Abu Hejleh as lead sponsor.

NCT NCT03688347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03688347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Microbiome in Lung Cancer and Other Malignancies
Lead sponsor
Taher Abu Hejleh
Phase
Observational
Overall status
Completed
Start date
August 30, 2018
Completion date
May 9, 2022
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, lung cancer, malignancy